Subject Rankings

AstraZeneca, Sweden Rankings 2024

Agriculture and Forestry, Art, Design and Architecture, Business and Management, Economics and Econometrics, Education, Engineering and Technology, History, Philosophy, Theology, Law, Medicine and Health Sciences, Natural Sciences and Social Sciences and their 256 sub-branches can analyse the world, countries and regions. You can also analyse them according to i10 index and citation numbers. *Jul 17, 2024 According to Total H Index. BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field 'others' (652.491) scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. See also: University Subject Rankings

Rankings
University / Institution:
# 1
Country:
# 217
Region:
# 6,034
World:
# 17,840
H-Index
Total:
82
Last 6 Year:
41
Last 6 Year/Total:
0.500
i10 Index
Total:
243
Last 6 Year:
129
Last 6 Year/Total:
0.531
Citation
Total:
23,398
Last 6 Year:
6,904
Last 6 Year/Total:
0.295
Rankings
University / Institution:
# 2
Country:
# 299
Region:
# 7,925
World:
# 23,348
H-Index
Total:
75
Last 6 Year:
61
Last 6 Year/Total:
0.813
i10 Index
Total:
142
Last 6 Year:
128
Last 6 Year/Total:
0.901
Citation
Total:
24,874
Last 6 Year:
14,787
Last 6 Year/Total:
0.594
Rankings
University / Institution:
# 3
Country:
# 341
Region:
# 8,986
World:
# 26,257
H-Index
Total:
73
Last 6 Year:
38
Last 6 Year/Total:
0.521
i10 Index
Total:
176
Last 6 Year:
77
Last 6 Year/Total:
0.438
Citation
Total:
20,385
Last 6 Year:
5,597
Last 6 Year/Total:
0.275
Homogeneous catalysis
reaction mechanisms
molecular modeling
Rankings
University / Institution:
# 4
Country:
# 431
Region:
# 11,332
World:
# 32,931
H-Index
Total:
68
Last 6 Year:
33
Last 6 Year/Total:
0.485
i10 Index
Total:
189
Last 6 Year:
89
Last 6 Year/Total:
0.471
Citation
Total:
12,792
Last 6 Year:
3,751
Last 6 Year/Total:
0.293
Quantitative Clinical Pharmacology
Anesthesiology
Pharmacometrics
Clinical Pharmacology
Rankings
University / Institution:
# 5
Country:
# 467
Region:
# 11,976
World:
# 34,741
H-Index
Total:
67
Last 6 Year:
21
Last 6 Year/Total:
0.313
i10 Index
Total:
131
Last 6 Year:
40
Last 6 Year/Total:
0.305
Citation
Total:
16,680
Last 6 Year:
1,690
Last 6 Year/Total:
0.101
Rankings
University / Institution:
# 6
Country:
# 591
Region:
# 15,056
World:
# 43,440
H-Index
Total:
62
Last 6 Year:
35
Last 6 Year/Total:
0.565
i10 Index
Total:
284
Last 6 Year:
128
Last 6 Year/Total:
0.451
Citation
Total:
15,965
Last 6 Year:
5,157
Last 6 Year/Total:
0.323
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
Rankings
University / Institution:
# 7
Country:
# 601
Region:
# 15,401
World:
# 44,486
H-Index
Total:
61
Last 6 Year:
48
Last 6 Year/Total:
0.787
i10 Index
Total:
93
Last 6 Year:
78
Last 6 Year/Total:
0.839
Citation
Total:
21,347
Last 6 Year:
10,527
Last 6 Year/Total:
0.493
Clinical Trials
Longitudinal Data
Evidence Synthesis
Rankings
University / Institution:
# 8
Country:
# 628
Region:
# 16,152
World:
# 46,611
H-Index
Total:
60
Last 6 Year:
49
Last 6 Year/Total:
0.817
i10 Index
Total:
108
Last 6 Year:
98
Last 6 Year/Total:
0.907
Citation
Total:
17,830
Last 6 Year:
10,690
Last 6 Year/Total:
0.600
Rankings
University / Institution:
# 9
Country:
# 779
Region:
# 19,741
World:
# 56,740
H-Index
Total:
56
Last 6 Year:
43
Last 6 Year/Total:
0.768
i10 Index
Total:
162
Last 6 Year:
135
Last 6 Year/Total:
0.833
Citation
Total:
14,048
Last 6 Year:
7,241
Last 6 Year/Total:
0.515
Rankings
University / Institution:
# 10
Country:
# 822
Region:
# 20,529
World:
# 58,683
H-Index
Total:
56
Last 6 Year:
27
Last 6 Year/Total:
0.482
i10 Index
Total:
183
Last 6 Year:
52
Last 6 Year/Total:
0.284
Citation
Total:
11,283
Last 6 Year:
2,658
Last 6 Year/Total:
0.236
Immunotherapy
microbiome
and targeted therapy for oncology
Rankings
University / Institution:
# 11
Country:
# 838
Region:
# 20,777
World:
# 59,529
H-Index
Total:
55
Last 6 Year:
45
Last 6 Year/Total:
0.818
i10 Index
Total:
85
Last 6 Year:
78
Last 6 Year/Total:
0.918
Citation
Total:
23,489
Last 6 Year:
17,208
Last 6 Year/Total:
0.733
Rankings
University / Institution:
# 12
Country:
# 905
Region:
# 22,739
World:
# 64,676
H-Index
Total:
54
Last 6 Year:
28
Last 6 Year/Total:
0.519
i10 Index
Total:
133
Last 6 Year:
73
Last 6 Year/Total:
0.549
Citation
Total:
10,331
Last 6 Year:
3,384
Last 6 Year/Total:
0.328
statistics
clinical trials
regulatory submission for drug development
Rankings
University / Institution:
# 13
Country:
# 929
Region:
# 23,316
World:
# 66,405
H-Index
Total:
53
Last 6 Year:
38
Last 6 Year/Total:
0.717
i10 Index
Total:
137
Last 6 Year:
73
Last 6 Year/Total:
0.533
Citation
Total:
14,877
Last 6 Year:
4,290
Last 6 Year/Total:
0.288
Rankings
University / Institution:
# 14
Country:
# 935
Region:
# 23,384
World:
# 66,588
H-Index
Total:
53
Last 6 Year:
37
Last 6 Year/Total:
0.698
i10 Index
Total:
122
Last 6 Year:
82
Last 6 Year/Total:
0.672
Citation
Total:
10,902
Last 6 Year:
4,940
Last 6 Year/Total:
0.453
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
Rankings
University / Institution:
# 15
Country:
# 974
Region:
# 24,106
World:
# 68,310
H-Index
Total:
53
Last 6 Year:
25
Last 6 Year/Total:
0.472
i10 Index
Total:
99
Last 6 Year:
61
Last 6 Year/Total:
0.616
Citation
Total:
7,710
Last 6 Year:
1,984
Last 6 Year/Total:
0.257
Rankings
University / Institution:
# 16
Country:
# 1,004
Region:
# 24,790
World:
# 70,362
H-Index
Total:
52
Last 6 Year:
35
Last 6 Year/Total:
0.673
i10 Index
Total:
103
Last 6 Year:
72
Last 6 Year/Total:
0.699
Citation
Total:
9,267
Last 6 Year:
3,661
Last 6 Year/Total:
0.395
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
Rankings
University / Institution:
# 17
Country:
# 1,044
Region:
# 25,735
World:
# 72,954
H-Index
Total:
51
Last 6 Year:
41
Last 6 Year/Total:
0.804
i10 Index
Total:
131
Last 6 Year:
104
Last 6 Year/Total:
0.794
Citation
Total:
11,778
Last 6 Year:
9,161
Last 6 Year/Total:
0.778
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
Rankings
University / Institution:
# 18
Country:
# 1,050
Region:
# 25,915
World:
# 73,476
H-Index
Total:
51
Last 6 Year:
38
Last 6 Year/Total:
0.745
i10 Index
Total:
94
Last 6 Year:
82
Last 6 Year/Total:
0.872
Citation
Total:
13,081
Last 6 Year:
8,787
Last 6 Year/Total:
0.672
Rankings
University / Institution:
# 19
Country:
# 1,084
Region:
# 26,644
World:
# 75,273
H-Index
Total:
51
Last 6 Year:
28
Last 6 Year/Total:
0.549
i10 Index
Total:
70
Last 6 Year:
55
Last 6 Year/Total:
0.786
Citation
Total:
37,861
Last 6 Year:
7,894
Last 6 Year/Total:
0.208
Rankings
University / Institution:
# 20
Country:
# 1,215
Region:
# 29,933
World:
# 84,089
H-Index
Total:
49
Last 6 Year:
23
Last 6 Year/Total:
0.469
i10 Index
Total:
110
Last 6 Year:
51
Last 6 Year/Total:
0.464
Citation
Total:
8,200
Last 6 Year:
2,159
Last 6 Year/Total:
0.263
Rankings
University / Institution:
# 21
Country:
# 1,251
Region:
# 30,652
World:
# 86,231
H-Index
Total:
48
Last 6 Year:
34
Last 6 Year/Total:
0.708
i10 Index
Total:
102
Last 6 Year:
79
Last 6 Year/Total:
0.775
Citation
Total:
16,842
Last 6 Year:
8,395
Last 6 Year/Total:
0.498
Cardiovascular
Drug Discovery & Development
Rankings
University / Institution:
# 22
Country:
# 1,302
Region:
# 31,673
World:
# 88,705
H-Index
Total:
48
Last 6 Year:
21
Last 6 Year/Total:
0.438
i10 Index
Total:
81
Last 6 Year:
39
Last 6 Year/Total:
0.481
Citation
Total:
7,957
Last 6 Year:
1,459
Last 6 Year/Total:
0.183
Lymphocyte Biology
Lymphomagenesis
Therapeutics
Rankings
University / Institution:
# 23
Country:
# 1,320
Region:
# 32,059
World:
# 89,970
H-Index
Total:
47
Last 6 Year:
38
Last 6 Year/Total:
0.809
i10 Index
Total:
62
Last 6 Year:
51
Last 6 Year/Total:
0.823
Citation
Total:
23,125
Last 6 Year:
9,269
Last 6 Year/Total:
0.401
replicability
reproduciblity
in-vivo
experimental design
sex bias
Rankings
University / Institution:
# 24
Country:
# 1,329
Region:
# 32,291
World:
# 90,610
H-Index
Total:
47
Last 6 Year:
35
Last 6 Year/Total:
0.745
i10 Index
Total:
78
Last 6 Year:
66
Last 6 Year/Total:
0.846
Citation
Total:
16,136
Last 6 Year:
11,205
Last 6 Year/Total:
0.694
Rankings
University / Institution:
# 25
Country:
# 1,355
Region:
# 32,929
World:
# 92,221
H-Index
Total:
47
Last 6 Year:
28
Last 6 Year/Total:
0.596
i10 Index
Total:
133
Last 6 Year:
47
Last 6 Year/Total:
0.353
Citation
Total:
37,409
Last 6 Year:
7,463
Last 6 Year/Total:
0.199
AD Scientific Index - Subject Rankings - 2024 H INDEX i10 INDEX CITATION
University /
Institution
Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 217 6,034 17,840
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

82 41 0.500 243 129 0.531 23,398 6,904 0.295
2 299 7,925 23,348
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Medical Oncology

Oncology |

75 61 0.813 142 128 0.901 24,874 14,787 0.594
3 341 8,986 26,257
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Drug metabolism and disposition |

73 38 0.521 176 77 0.438 20,385 5,597 0.275
4 431 11,332 32,931
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Homogeneous catalysis | reaction mechanisms | molecular modeling |

68 33 0.485 189 89 0.471 12,792 3,751 0.293
5 467 11,976 34,741
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Anesthesiology and Reanimation

Quantitative Clinical Pharmacology | Anesthesiology | Pharmacometrics | Clinical Pharmacology |

67 21 0.313 131 40 0.305 16,680 1,690 0.101
6 591 15,056 43,440
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

transporters | drug metabolism | pharmacokinetics |

62 35 0.565 284 128 0.451 15,965 5,157 0.323
7 601 15,401 44,486
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Developing inhibitors of the DNA Damage Response into new medicines for cancer patients |

61 48 0.787 93 78 0.839 21,347 10,527 0.493
8 628 16,152 46,611
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Clinical Trials | Longitudinal Data | Evidence Synthesis |

60 49 0.817 108 98 0.907 17,830 10,690 0.600
9 779 19,741 56,740
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Engineering & Technology / Computer Science

Data Science |

56 43 0.768 162 135 0.833 14,048 7,241 0.515
10 822 20,529 58,683
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Cardiology

cardiology | lipids | hypertension |

56 27 0.482 183 52 0.284 11,283 2,658 0.236
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
11 838 20,777 59,529
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Immunology

Immunotherapy | microbiome | and targeted therapy for oncology |

55 45 0.818 85 78 0.918 23,489 17,208 0.733
12 905 22,739 64,676
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

CAR-T | Treg | iPSC | genome editing | lentiviral and AAV vectors |

54 28 0.519 133 73 0.549 10,331 3,384 0.328
13 929 23,316 66,405
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

statistics | clinical trials | regulatory submission for drug development |

53 38 0.717 137 73 0.533 14,877 4,290 0.288
14 935 23,384 66,588
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Proteomics | Cell Biology | Bioanalytical Chemistry |

53 37 0.698 122 82 0.672 10,902 4,940 0.453
15 974 24,106 68,310
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

drug discovery and development | viruses and epithelial biology | non coding RNA | post translational modification |

53 25 0.472 99 61 0.616 7,710 1,984 0.257
16 1,004 24,790 70,362
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

52 35 0.673 103 72 0.699 9,267 3,661 0.395
17 1,044 25,735 72,954
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Cheminformatics | Drug Discovery | Machine Learning | Semantic Web Technologies | Open Innovation |

51 41 0.804 131 104 0.794 11,778 9,161 0.778
18 1,050 25,915 73,476
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

meta-analysis | missing data | statistics | biostatistics | miscellaneous statistical theory |

51 38 0.745 94 82 0.872 13,081 8,787 0.672
19 1,084 26,644 75,273
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

genomics | genetics | oncology | DNA sequencing | bioinformatics |

51 28 0.549 70 55 0.786 37,861 7,894 0.208
20 1,215 29,933 84,089
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cancer |

49 23 0.469 110 51 0.464 8,200 2,159 0.263
21 1,251 30,652 86,231
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Physiology

Physiology | Metabolism | Transgenic | CRISPR |

48 34 0.708 102 79 0.775 16,842 8,395 0.498
22 1,302 31,673 88,705
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cardiovascular | Drug Discovery & Development |

48 21 0.438 81 39 0.481 7,957 1,459 0.183
23 1,320 32,059 89,970
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lymphocyte Biology | Lymphomagenesis | Therapeutics |

47 38 0.809 62 51 0.823 23,125 9,269 0.401
24 1,329 32,291 90,610
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

replicability | reproduciblity | in-vivo | experimental design | sex bias |

47 35 0.745 78 66 0.846 16,136 11,205 0.694
25 1,355 32,929 92,221
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Genomics | Bioinformatics | Oncology | Data Science |

47 28 0.596 133 47 0.353 37,409 7,463 0.199